Vanderbilt Institute For Chemical Biology

Gary Sulikowski, Stevenson Professor of Chemistry, was named director of the Vanderbilt Institute for Chemical Biology in 2017. Since then, he has stewarded VICB’s growth and research operations. He shares how VICB has contributed to translational research, some of the research he's most excited about, and what makes Vanderbilt a rare place where powerful collaborative research can achieve its potential. Read More

By targeting a notoriously undruggable protein found in many cancers, the discovery of BI-0474 may pave the way for new cancer treatments. Shared on opnMe.com by Boehringer Ingelheim, this innovative molecule is available for global researchers to explore new research avenues. Read More

The World Health Organization ranks antimicrobial resistance as one of the top ten global health risks. Vanderbilt researchers led by Houra Merrikh identified the first anti-evolution compound that targets AMR during treatment of infections with antibiotics. Read More